Table 2 The patient characteristics
From: The salt-taste threshold in untreated hypertensive patients
Variables | Control | HTN | p |
|---|---|---|---|
Patient number | 66 | 133 | |
Male, n (%) | 22 (33.3%) | 71 (53.4%) | 0.010 |
Age, years | 53.6 ± 12.5 | 51.7 ± 10.9 | 0.273 |
Height, cm | 162.4 ± 9.5 | 165.1 ± 8.9 | 0.054 |
Weight, kg | 66.0 ± 12.9 | 68.8 ± 11.5 | 0.115 |
BMI, kg/m2 | 24.8 ± 3.2 | 25.2 ± 3.2 | 0.492 |
BSA, m2 | 1.72 ± 0.21 | 1.77 ± 0.18 | 0.073 |
Serum sodium, mEq/L | 140.0 ± 2.4 | 139.7 ± 2.6 | 0.390 |
Serum potassium, mEq/L | 4.47 ± 0.37 | 4.36 ± 0.36 | 0.057 |
Blood urea nitrogen, mg/dL | 13.2 ± 3.8 | 13.1 ± 3.5 | 0.858 |
Serum creatinine mg/dL | 0.74 ± 0.15 | 0.78 ± 0.16 | 0.150 |
Urinary sodium, mEq/d | 117.9 ± 57.2 | 140.9 ± 59.8 | 0.011 |
Urinary potassium, mEq/d | 52.2 ± 20.8 | 50.4 ± 24.2 | 0.638 |
Urinary sodium/potassium | 2.46 ± 1.07 | 3.03 ± 1.18 | 0.003 |
Plasma renin activity, ng/ml/h | 1.85 ± 1.53 | 1.83 ± 1.41 | 0.936 |
Serum aldosterone, pg/ml | 89.6 ± 68.9 | 79.4 ± 55.1 | 0.278 |